tradingkey.logo
搜索

Gyre Therapeutics Inc

GYRE
添加自选
5.650USD
-0.340-5.68%
收盘 07-29 16:00美东报价延迟15分钟
516.05M总市值
亏损市盈率 TTM

GYRE 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Gyre Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Gyre Therapeutics Inc财报日历

最新发布
5月 7, 2026
每股收益 / 预测值
-0.10/-0.07
营业收入 / 预测值
22.52M/31.61M
报告期
FY2025 财报
营业收入(YoY)
116.59M
10.24%
每股收益(YoY)
0.06
-60.38%
分析师评级
BUY
2026/07/29
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-404.84%-0.10
-1541.74%-0.02
202.90%0.04
-87.98%0.00
-65.49%0.03
99.67%0.00
-79.02%0.01
104.21%0.04
-12.47%0.09
98.18%-0.35
--0.06
---0.98
--0.10
---19.10
----
----
----
----
----
----
营业收入
2.09%22.52M
33.45%37.20M
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-75.43%27.87M
-20.45%25.49M
--25.23M
--27.17M
--113.45M
--32.04M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-45.88%794.00K
20.14%2.44M
157.45%2.30M
-31.72%1.13M
净利润
-422.13%-8.69M
-1640.40%-1.72M
221.17%3.61M
-87.47%442.00K
-64.18%2.70M
99.89%-99.00K
-71.73%1.12M
242.72%3.53M
2796.92%7.53M
-120.36%-89.14M
181.41%3.98M
-104.79%-2.47M
101.79%260.00K
-99.00%-40.45M
80.65%-4.88M
359.09%51.63M
35.22%-14.54M
-7.52%-20.33M
-57.41%-25.24M
-15.54%-19.93M
利润率
-358.60%-43.78%
-279.90%-3.67%
73.33%19.42%
-67.28%5.89%
-53.70%16.93%
102.84%2.04%
-52.19%11.21%
--17.99%
--36.56%
---72.01%
--23.44%
----
----
----
----
----
----
----
----
----
毛利率
-1.45%94.55%
-0.48%95.31%
-1.63%94.67%
-1.29%95.70%
-0.47%95.95%
-0.14%95.78%
-0.07%96.24%
--96.95%
--96.40%
--95.91%
--96.30%
----
----
----
----
----
----
----
----
----
资产负债率
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
----
----
营业收入
2.09%22.52M
33.45%37.20M
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-75.43%27.87M
-20.45%25.49M
--25.23M
--27.17M
--113.45M
--32.04M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-45.88%794.00K
20.14%2.44M
157.45%2.30M
-31.72%1.13M
营业利润
-399.25%-6.80M
-81.90%120.00K
63.60%6.92M
-33.45%2.17M
-71.84%2.27M
-97.63%663.00K
-66.84%4.23M
228.27%3.26M
277.07%8.07M
679.01%27.94M
347.08%12.76M
55.50%-2.54M
66.73%-4.56M
76.25%-4.83M
79.52%-5.17M
71.30%-5.71M
38.94%-13.70M
-7.81%-20.31M
-56.70%-25.23M
-14.71%-19.91M
净利润
-422.13%-8.69M
-1640.40%-1.72M
221.17%3.61M
-87.47%442.00K
-64.18%2.70M
99.89%-99.00K
-71.73%1.12M
242.72%3.53M
2796.92%7.53M
-120.36%-89.14M
181.41%3.98M
-104.79%-2.47M
101.79%260.00K
-99.00%-40.45M
80.65%-4.88M
359.09%51.63M
35.22%-14.54M
-7.52%-20.33M
-57.41%-25.24M
-15.54%-19.93M
流动资产
34.02%91.73M
58.01%102.37M
79.85%98.58M
70.57%91.28M
9.13%68.45M
13.22%64.79M
967.99%54.81M
602.35%53.52M
347.57%62.72M
102.87%57.22M
-83.03%5.13M
-90.63%7.62M
-61.82%14.01M
-45.21%28.21M
-59.11%30.25M
-16.03%81.31M
-68.50%36.70M
-42.49%51.48M
-31.50%73.96M
-20.21%96.83M
流动负债总额
4.20%19.79M
-6.30%18.29M
8.13%15.91M
8.64%16.92M
-2.54%18.99M
-2.65%19.52M
725.35%14.72M
457.61%15.57M
184.72%19.49M
19.16%20.05M
8.45%1.78M
-35.21%2.79M
-48.11%6.84M
18.77%16.82M
-90.47%1.64M
-72.31%4.31M
-6.99%13.19M
-20.40%14.16M
2.56%17.25M
13.93%15.57M
总资产
24.83%162.01M
32.48%166.13M
27.26%159.38M
26.23%152.65M
6.38%129.79M
7.61%125.41M
1156.92%125.24M
875.71%120.93M
550.72%122.01M
309.71%116.54M
-67.88%9.96M
-85.13%12.39M
-53.44%18.75M
-48.90%28.44M
-60.50%31.02M
-18.09%83.37M
-66.18%40.27M
-41.31%55.66M
-29.75%78.54M
-17.70%101.79M
总负债
-1.80%25.03M
-11.68%23.85M
-17.92%21.97M
-15.88%23.20M
-23.32%25.49M
-29.06%27.00M
315.17%26.77M
272.79%27.58M
385.67%33.24M
126.25%38.06M
292.15%6.45M
71.63%7.40M
-48.11%6.84M
15.45%16.82M
-90.76%1.64M
-74.06%4.31M
-11.99%13.19M
-22.39%14.57M
0.32%17.80M
12.90%16.62M
总权益
31.33%136.99M
44.59%142.28M
39.54%137.41M
38.67%129.44M
17.50%104.30M
25.39%98.40M
2699.94%98.47M
1768.79%93.35M
1106.78%88.77M
575.34%78.47M
-88.03%3.52M
-93.68%5.00M
-72.84%7.36M
-71.72%11.62M
-51.63%29.38M
-7.16%79.06M
-73.98%27.08M
-45.98%41.09M
-35.43%60.74M
-21.84%85.16M
经营净额
2565.12%3.18M
-103.95%-5.63M
170.92%4.68M
138.01%2.09M
-104.47%-129.00K
-107.30%-2.76M
153.65%1.73M
-122.30%-5.49M
146.40%2.88M
2662.44%37.80M
55.79%-3.22M
79.90%-2.47M
48.41%-6.22M
91.66%-1.48M
66.31%-7.28M
38.91%-12.29M
50.53%-12.05M
20.07%-17.68M
-66.05%-21.60M
-32.95%-20.12M
投资净额
-255.31%-3.06M
192.22%1.85M
47.76%-1.25M
63.23%-3.04M
127.24%1.97M
91.97%-2.00M
---2.39M
-272.53%-8.27M
-1856.69%-7.22M
-49052.94%-24.97M
--0.00
-90.93%4.79M
-83.59%411.00K
-98.22%51.00K
-100.00%0.00
393.94%52.87M
-90.92%2.50M
-89.60%2.87M
133.09%7.04M
144.52%10.70M
融资净额
-98.44%21.00K
-67.01%318.00K
12.65%365.00K
14227.56%22.35M
104.26%1.34M
-93.67%964.00K
121.92%324.00K
104.46%156.00K
108.48%658.00K
--15.24M
96.72%-1.48M
---3.50M
-48612.50%-7.76M
--0.00
-46045.92%-45.03M
100.00%0.00
-99.97%16.00K
--0.00
230.67%98.00K
-100.01%-4.00K

常见问题

Gyre Therapeutics Inc的总收入是多少?

根据Gyre Therapeutics Inc的FY2025财报,总收入达到了116.59M(同比变化105.76M)。

Gyre Therapeutics Inc的流动资产是多少?

根据Gyre Therapeutics Inc的FY2025财报,流动资产为102.37M(同比变化58.01)。

Gyre Therapeutics Inc的总资产是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的总资产为166.13M(同比变化32.48)。

Gyre Therapeutics Inc的总负债是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的总负债为23.85M(同比变化-11.68)。

Gyre Therapeutics Inc的总权益是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的总权益为142.28M(同比变化44.59)。

Gyre Therapeutics Inc的净营业收入是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的净营业收入为11.49M(同比变化-29.19)。

Gyre Therapeutics Inc的净投资是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的净投资为-474.00K(同比变化97.62)。

Gyre Therapeutics Inc的净融资是多少?

根据Gyre Therapeutics Inc的FY2025财报,Gyre Therapeutics Inc的净融资为24.38M(同比变化1059.75)。

Gyre Therapeutics Inc的每股收益(EPS)是多少?

根据Gyre Therapeutics Inc的FY2025财报,每股收益(EPS)为0.06(同比变化-60.38)。

Gyre Therapeutics Inc的净利润是多少?

根据Gyre Therapeutics Inc的FY2025财报,净利润为5.03M(同比变化-58.40)。

Gyre Therapeutics Inc的净利润率是多少?

根据Gyre Therapeutics Inc的FY2025财报,净利润率为8.47(同比变化-49.93)。

Gyre Therapeutics Inc的毛利率是多少?

根据Gyre Therapeutics Inc的FY2025财报,毛利率为95.35(同比变化-1.01)。

Gyre Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Gyre Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为5.94(同比变化-88.33)。

Gyre Therapeutics Inc的资产回报率(ROA)是多少?

根据Gyre Therapeutics Inc的FY2025财报,资产回报率(ROA)为6.78(同比变化-54.19)。

Gyre Therapeutics Inc的营业利润是多少?

根据Gyre Therapeutics Inc的FY2025财报,营业利润为11.49M(同比变化-29.19)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有